CATEGORY E · E-18API

Deucravacitinib

氘可来昔替尼
CAS Registry No.
1609392-27-9
Terminal API
Deucravacitinib
Molecular Weight
425.5
Product Type
API

Identification & Structure

Chemical structure of Deucravacitinib
2D Structure

[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4

Product CodeE-18
Product TypeAPI
CAS Number1609392-27-9
Molecular FormulaC20H22N8O3
Molecular Weight425.5
IUPAC Name6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
SMILES[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4
InChIKeyBZZKEPGENYLQSC-FIBGUPNXSA-N
PubChem CID134821691
Quality ParametersSpecification per batch COA, available on request

Related Terminal API

This catalog entry is the API Deucravacitinib itself, not an intermediate. Availability depends on the patent status in the destination market; please see the patent notice below.

Direct Inquiries

Request a Quote & Documents

Tell us the quantity, specification and destination. We will reply by email with pricing, lead time and the documents available.

· Email: inquiry@candidpharm.com
· We will reply by email
· Mutual NDA available on request

Documents on Request

  • Batch Certificate of Analysis (COA)
  • Safety Data Sheet (SDS / MSDS)
  • Regulatory documents, subject to manufacturer

Patent Notice

Products listed on this site that are protected by valid patents are not offered for sale in any country where such sale would infringe those patents. Buyers are solely responsible for determining the patent status of any product in their jurisdiction. Where applicable, supply is limited to research purposes or to jurisdictions in which the relevant patents have expired or do not apply.